BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Sarcomas AND ROS1, ROS, 6098, ENSG00000047936, P08922, MCF3, RP1-179P9_1 AND Prognosis
4394 results:

  • 1. Analysis of the effects of M2 macrophage-derived PDE4C on the prognosis, metastasis and immunotherapy benefit of osteosarcoma.
    Pan F; Pan R; Hu R; Zhang H; Lei S; Zhang L; Zhou C; Zeng Z; Tian X; Xie Q
    J Cell Mol Med; 2024 May; 28(10):e18395. PubMed ID: 38774995
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Primary Ewing's sarcoma of the uterine cervix: a case report and review of the literature.
    Xiao Y; Zhi Y; Cao G; Ma H; Gao J; Li F
    J Cancer Res Clin Oncol; 2024 May; 150(5):267. PubMed ID: 38769118
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Case report: Sintilimab combined with anlotinib as neoadjuvant chemotherapy for metastatic bone tumor resection in patients with PSC.
    Bao Z; Yu X; Zheng K; Zhai K; Cui H; Xu M
    Front Immunol; 2024; 15():1372279. PubMed ID: 38756778
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Navigating diagnostic challenges-distinguishing malignant melanoma and clear cell sarcoma of soft tissues: a case report and review of the literature.
    Abdouh S; Boujguenna I; Soleh A; Abkari I; Rais H
    J Med Case Rep; 2024 May; 18(1):249. PubMed ID: 38755643
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. PI3K/mTOR inhibition induces tumour microenvironment remodelling and sensitises pS6
    De Wispelaere W; Annibali D; Tuyaerts S; Messiaen J; Antoranz A; Shankar G; Dubroja N; Herreros-Pomares A; Baiden-Amissah REM; Orban MP; Delfini M; Berardi E; Van Brussel T; Schepers R; Philips G; Boeckx B; Baietti MF; Congedo L; HoWangYin KY; Bayon E; Van Rompuy AS; Leucci E; Tabruyn SP; Bosisio F; Mazzone M; Lambrechts D; Amant F
    Clin Transl Med; 2024 May; 14(5):e1655. PubMed ID: 38711203
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Tumor mitochondrial oxidative phosphorylation stimulated by the nuclear receptor RORγ represents an effective therapeutic opportunity in osteosarcoma.
    Zheng J; Wang Q; Chen J; Cai G; Zhang Z; Zou H; Zou JX; Liu Q; Ji S; Shao G; Li H; Li S; Chen HW; Lu L; Yuan Y; Liu P; Wang J
    Cell Rep Med; 2024 May; 5(5):101519. PubMed ID: 38692271
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. p53-Armed Oncolytic Virotherapy Improves Radiosensitivity in Soft-Tissue Sarcoma by Suppressing BCL-xL Expression.
    Komatsubara T; Tazawa H; Hasei J; Omori T; Sugiu K; Mochizuki Y; Demiya K; Yoshida A; Fujiwara T; Kunisada T; Urata Y; Kagawa S; Ozaki T; Fujiwara T
    Acta Med Okayama; 2024 Apr; 78(2):151-161. PubMed ID: 38688833
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Targeting KRAS in pancreatic cancer.
    Stickler S; Rath B; Hamilton G
    Oncol Res; 2024; 32(5):799-805. PubMed ID: 38686056
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Importance of CD8 Tex cell-associated gene signatures in the prognosis and immunology of osteosarcoma.
    Lu Y; Cao N; Zhao M; Zhang G; Zhang Q; Wang L
    Sci Rep; 2024 Apr; 14(1):9769. PubMed ID: 38684858
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. A Semiautomated Proteomics and Phosphoproteomics Protocol for the Identification of Novel Therapeutic Targets and Predictive Biomarkers in In Vivo Xenograft Models of Pediatric Cancers.
    Lim Kam Sian TCC; Sun C; Cain JE; Steele JR; Hanchapola I; Stoychev S; Schittenhelm RB; Faridi P
    Methods Mol Biol; 2024; 2806():229-242. PubMed ID: 38676807
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. [Analysis of 41 cases of non-metastatic Ewing's sarcoma in children].
    Yuan Q; Han YL; Pan C; Tang JY; Gao YJ
    Zhongguo Dang Dai Er Ke Za Zhi; 2024 Apr; 26(4):365-370. PubMed ID: 38660900
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Upregulation of circ_0076684 in osteosarcoma facilitates malignant processes by mediating miRNAs/CUX1.
    Cai P; Fu X; Li X; Zhao W
    J Orthop Surg Res; 2024 Apr; 19(1):260. PubMed ID: 38659042
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Case report: Pathological complete response induced by immunochemotherapy in a case of Pulmonary Sarcomatoid Carcinoma staged IIIA-N2.
    Guo Y; Liu X; Tang H; Qiu Z; Ma F; Hu A; Liu C; Wang Y
    Front Immunol; 2024; 15():1374270. PubMed ID: 38650938
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Extramedullary infiltration in pediatric acute myeloid leukemia: Results from the Therapeutically Applicable Research to Generate Effective Treatments (TARGET) initiative.
    Li W; Shi M; Zhou P; Liu Y; Liu X; Xiao X; Zuo S; Bai Y; Sun K
    Pediatr Blood Cancer; 2024 Jul; 71(7):e31014. PubMed ID: 38644612
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Sarcoma of the uterine cervix: experience of a single center.
    Yuan H; Li L; Li N; Yao H
    World J Surg Oncol; 2024 Apr; 22(1):104. PubMed ID: 38637834
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Necroptosis-related lncRNA-based novel signature to predict the prognosis and immune landscape in soft tissue sarcomas.
    Long Q; Li Z; Yang W; Huang K; Du G
    J Cancer Res Clin Oncol; 2024 Apr; 150(4):203. PubMed ID: 38635069
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Transient Receptor Potential Ankyrin 1 Ion Channel Is Expressed in Osteosarcoma and Its Activation Reduces Viability.
    Hudhud L; Rozmer K; Kecskés A; Pohóczky K; Bencze N; Buzás K; Szőke É; Helyes Z
    Int J Mol Sci; 2024 Mar; 25(7):. PubMed ID: 38612571
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. A rare presentation of primary cardiac myxofibrosarcoma: Case report and literature review.
    Soltani S; Garousi M; Mirzaee E; Koolaji S; Nazari H; Emami S; Zare Mehrjardi A; Arefpour AM
    Cancer Rep (Hoboken); 2024 Apr; 7(4):e2033. PubMed ID: 38600050
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Radiotherapy combined with anti-PD-1 and TKI for primary cardiac angiosarcoma considering the joint assessment of TLSs and PD-L1: a case report.
    Deng S; Yang X; He L; Zhang Q; Zhao C; Meng H
    J Cardiothorac Surg; 2024 Apr; 19(1):194. PubMed ID: 38594687
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Evaluation of the efficacy and safety of immunotherapy in sarcoma: a two-center study.
    Liao Z; Teng J; Li T; Liu H; Li T; Zhang C; Xing R; Teng S; Yang Y; Zhao J; Xiao W; Zhang G; Li MJ; Yao W; Yang J
    Front Immunol; 2024; 15():1292325. PubMed ID: 38585276
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 220.